ResearcherCentral South UniversityNo recent work listed
Fanhua Kong
Matched on ORCID iD 0000-0003-3126-2508; OpenAlex author ID A5103185962. Sources: OpenAlex.
Their work
- Papers
- 3
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 8
2020: 1 paper · 2021: 2 papers
Papers 3
- HELLS, a chromatin remodeler is highly expressed in pancreatic cancer and downregulation of it impairs tumor growth and sensitizes to cisplatin by reexpressing… Co-author DOI 10.1002/cam4.3627↗
- Integrating Network Pharmacology and Experimental Verification to Explore the Mechanism of Effect of Zuojin Pills in Pancreatic Cancer Treatment. Co-author DOI 10.2147/dddt.s323360↗
- Downregulation of METTL14 increases apoptosis and autophagy induced by cisplatin in pancreatic cancer cells. Co-author DOI 10.1016/j.biocel.2020.105731↗
Closest collaborators
The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Kunpeng Wang · 2 shared papers, 2021 · strength 0.29
- Paper Integrating Network Pharmacology and Experimental Verification to Explore the Mechanism of Effect of Zuojin Pills in Pa… DOI 10.2147/dddt.s323360↗
- Paper HELLS, a chromatin remodeler is highly expressed in pancreatic cancer and downregulation of it impairs tumor growth and… DOI 10.1002/cam4.3627↗
- Xiongying Miao · 2 shared papers, 2020–2021 · strength 0.27
- Paper Integrating Network Pharmacology and Experimental Verification to Explore the Mechanism of Effect of Zuojin Pills in Pa… DOI 10.2147/dddt.s323360↗
- Paper Downregulation of METTL14 increases apoptosis and autophagy induced by cisplatin in pancreatic cancer cells. DOI 10.1016/j.biocel.2020.105731↗
- Xuyang Hou · 2 shared papers, 2020–2021 · strength 0.26
- Jun He · 2 shared papers, 2020–2021 · strength 0.26
- Yan Zhou · 2 shared papers, 2020–2021 · strength 0.26
- Leping Yang · 2 shared papers, 2020–2021 · strength 0.26
- Yanwen Zheng · 1 shared paper, 2021 · strength 0.15
- Jinggang Mo · 1 shared paper, 2021 · strength 0.15
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.